CLINICAL_TRIALS ClinicalTrials.gov record update

5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05850377
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:10.853816+00:00
Published At: 2023-05-09T00:00:00+00:00
Record Updated At: 2023-05-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["High Grade Glioma", "Glioma", "Glioma, Malignant", "Neoplasms, Neuroepithelial", "Neuroectodermal Tumors", "Photosensitizing Agents", "Neoplasm Malignant", "Brain Neoplasms, Adult, Malignant", "Central Nervous System Neoplasms", "Brain Tumor", "Tumour, Residual"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-05-09"
protocolSection.identificationModule.nctId: "NCT05850377"
protocolSection.identificationModule.officialTitle: "5-Aminolevulinic Acid (5-ALA) Gliolan\u00ae: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas"
protocolSection.statusModule.overallStatus: "NOT_YET_RECRUITING"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.